# Cost-effectiveness of empagliflozin as a treatment for heart failure with reduced ejection fraction: an analysis from the Chinese healthcare perspective

> Research article (Journal of Thoracic Disease, 2022) · cited 23× · AI/ML

**Wikidata**: [openalex:W4282945529](https://www.wikidata.org/wiki/openalex:W4282945529)  
**Source**: https://4ort.xyz/entity/cost-effectiveness-of-empagliflozin-as-a-treatment-for-heart-failure-with-reduced-ejection-fraction-an-analysis-from-the